Market Analysis Report China Bioprocess Instruments Market

Your Catalyst to a Lucrative Business
China Bioprocess Instruments Market Share, Size, Key Players,
Technology, Application, Research and Forecasts to 2024 | Hexa
Research
“ The China bioprocess instruments market is expected to reach USD 3.06
billion by 2024.”
21 November 2018
The China bioprocess instruments market is expected to reach USD 3.06 billion by 2024 owing to the
improving economy, rising aging population and increasing prevalence of chronic diseases. Moreover,
increasing demand for single-use instruments in disposable applications is anticipated to augment the growth
over the projected period.
China was the second largest pharmaceutical market in the world, expected to grow USD 173 billion by 2024,
growing at a CAGR of 9.1% owing to the requirement of medication & drugs to cure deadly diseases. Huge
investment in biotechnology will primarily drive the growth of the market, as pharma companies deal in
innovations for developing medicines and drugs in line with the increasing prevalence of diseases.
With the patents of numerous biopharmaceutical products expiring by 2016, the market is anticipated to
provide a lucrative opportunity for contract manufacturers operating in the region. Approval of the trail plan
for new drug marketing authorization holder (MAH) in 2016 to produce, conduct clinical trials, and market
the products is expected to provide an impetus to the growth of the industry over the next few years.
Follow Us: